← SynDRA
HEXYLCAINE
SynDRA canonical compound SYN0004504 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | SCN5A |
|---|
| Mechanism of action | Sodium channel blocker |
|---|
| Indication | local anesthetic |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- SCN5A
- SCN1A
- SCN2A
- SCN3A
- SCN10A
- SCN11A
- SCN4A
- SCN7A
- SCN8A
- SCN9A
Mechanisms of action (all sources)
- Sodium channel blocker
- SCN1A BLOCKER
- Sodium channel alpha subunit blocker
- SCN5A BLOCKER
- SCN4A BLOCKER
- SCN7A BLOCKER
- SCN2A BLOCKER
- SCN9A BLOCKER
- SCN3A BLOCKER
- SCN11A BLOCKER
- SCN8A BLOCKER
- SCN10A BLOCKER
Cross-references
Synonyms
- osmocaine
- cyclain
- hexylcaine hydrochloride
- hexylcaine HCl
- Hexilcaina
- Osmocaine
- Hexylcainum
- Hexylcaine [INN]
- Cyclaine (TN)
- Hexilcaina [INN-Spanish]
- Hexylcainum [INN-Latin]
- Osmocaine (TN)
- (2-Cyclohexylamino-1-methylethyl) benzoate
- 1-(Cyclohexylamino)-2-propanol benzoate (ester)
- 1-(cyclohexylamino)propan-2-yl benzoate
- 2-Propanol, 1-(cyclohexylamino)-, benzoate (ester)
- RefChem:788314
- DTXCID7027839
- cyclaine /OD/ 1-(cyclohexylamino)-2-propanol benzoate ester
- Cyclain; Osmocaine
- CHEBI:34791
- Hexylcainc
- UNII-511IU0826Z
- Prestwick0_000788
- Prestwick1_000788
- Prestwick2_000788
- Prestwick3_000788
- HEXYLCAINE [WHO-DD]
- SCHEMBL34238
- BSPBio_000896
- SPBio_002835
- BPBio1_000986
- GTPL7196
- BDBM50225698
- EBC-26359
- NCGC00179382-01
- AB00514688
- NS00006142
Look up HEXYLCAINE in the interactive SynDRA portal →